Menu
Du musst dich anmelden oder registrieren, bevor du fortfahren kannst.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€1.24

€1.24

1.640%
0.02
1.640%
-

-

 
11.12.25 / Frankfurt WKN: A3CPDE / Name: Beauty Health Co., The / Stock / ? /

Beauty Health Co., The Stock

There is an upward development for Beauty Health Co., The compared to yesterday, with an increase of €0.020 (1.640%).
Our community identified positive and negative aspects for Beauty Health Co., The stock for the coming years. 0 users see the criterium "Growth compared to competition" as a plus for the Beauty Health Co., The stock. On the other hand our users think that "Growth compared to competition" could be a problem in the future.

Pros and Cons of Beauty Health Co., The in the next few years

Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Cons
?
M***** P*******
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2024-08-01

Analyzing the financials of Beauty Health Co., a significant player in its industry, provides an intriguing glimpse into its operational and financial health. The numbers reveal a mix of challenges and potential, with the company grappling with certain indicators that highlight the need for strategic focus. While some metrics are promising, others raise red flags, suggesting a more in-depth investigation is warranted.

Starting with the positives, one can highlight the revenue aspect. The company has demonstrated a total revenue of approximately $393.12 million, which, when broken down, translates to a revenue per share of around $3.04. This suggests that Beauty Health Co. is managing to generate substantial sales in its sector, despite the uphill battles it faces in profitability. When one considers the gross profit figure of $250.34 million, it becomes clear that there remains a healthy margin from sales, even if the company's overall profitability is currently hindered.

However, the negatives reveal a more complex picture. The company has posted a significant EBITDA loss of nearly $93.53 million, which highlights a struggle to maintain operational profitability. Accompanying this is the notable negative profit margin of approximately -20.49%, and an operating margin of -20.87%. These figures imply that the company is not only failing to generate profits but is also incurring losses on its core operations. With an earnings per share (EPS) at -0.66, this further emphasizes the challenges the company faces in delivering shareholder value.